Literature DB >> 23937253

Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008.

M Worni1, A W Castleberry, B Gloor, R Pietrobon, J C Haney, T A D'Amico, I Akushevich, M F Berry.   

Abstract

We examined outcomes and trends in surgery and radiation use for patients with locally advanced esophageal cancer, for whom optimal treatment isn't clear. Trends in surgery and radiation for patients with T1-T3N1M0 squamous cell or adenocarcinoma of the mid or distal esophagus in the Surveillance, Epidemiology, and End Results database from 1998 to 2008 were analyzed using generalized linear models including year as predictor; Surveillance, Epidemiology, and End Results doesn't record chemotherapy data. Local treatment was unimodal if patients had only surgery or radiation and bimodal if they had both. Five-year cancer-specific survival (CSS) and overall survival (OS) were analyzed using propensity-score adjusted Cox proportional-hazard models. Overall 5-year survival for the 3295 patients identified (mean age 65.1 years, standard deviation 11.0) was 18.9% (95% confidence interval: 17.3-20.7). Local treatment was bimodal for 1274 (38.7%) and unimodal for 2021 (61.3%) patients; 1325 (40.2%) had radiation alone and 696 (21.1%) underwent only surgery. The use of bimodal therapy (32.8-42.5%, P = 0.01) and radiation alone (29.3-44.5%, P < 0.001) increased significantly from 1998 to 2008. Bimodal therapy predicted improved CSS (hazard ratios [HR]: 0.68, P < 0.001) and OS (HR: 0.58, P < 0.001) compared with unimodal therapy. For the first 7 months (before survival curve crossing), CSS after radiation therapy alone was similar to surgery alone (HR: 0.86, P = 0.12) while OS was worse for surgery only (HR: 0.70, P = 0.001). However, worse CSS (HR: 1.43, P < 0.001) and OS (HR: 1.46, P < 0.001) after that initial timeframe were found for radiation therapy only. The use of radiation to treat locally advanced mid and distal esophageal cancers increased from 1998 to 2008. Survival was best when both surgery and radiation were used.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  esophageal cancer; esophagectomy; radiation therapy; surgery

Mesh:

Year:  2013        PMID: 23937253      PMCID: PMC3923844          DOI: 10.1111/dote.12123

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  27 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

2.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

3.  Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy.

Authors:  Henry S Park; Cary P Gross; Danil V Makarov; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-16       Impact factor: 7.038

4.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients.

Authors:  M Wang; X Z Gu; W B Yin; G J Huang; L J Wang; D W Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-02       Impact factor: 7.038

5.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Impact of lymph node staging on therapy of esophageal carcinoma.

Authors:  Enrique Vazquez-Sequeiros; Maurits J Wiersema; Jonathan E Clain; Ian D Norton; Michael J Levy; Yvonne Romero; Diva Salomao; Ross Dierkhising; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study.

Authors:  M Fok; J S Sham; D Choy; S W Cheng; J Wong
Journal:  Surgery       Date:  1993-02       Impact factor: 3.982

9.  Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research.

Authors:  P Ténière; J M Hay; A Fingerhut; P L Fagniez
Journal:  Surg Gynecol Obstet       Date:  1991-08

10.  Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial.

Authors:  S J Arnott; W Duncan; G R Kerr; P R Walbaum; E Cameron; W J Jack; W J Mackillop
Journal:  Radiother Oncol       Date:  1992-06       Impact factor: 6.280

View more
  12 in total

1.  Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.

Authors:  Loretta Erhunmwunsee; Brian R Englum; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  Ann Surg Oncol       Date:  2014-09-19       Impact factor: 5.344

2.  Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.

Authors:  Jeffrey Javidfar; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2015-11-11       Impact factor: 4.330

Review 3.  Cardiotoxicity of radiation therapy in esophageal cancer.

Authors:  Milan Vošmik; Miroslav Hodek; David Buka; Petra Sýkorová; Jakub Grepl; Petr Paluska; Simona Paulíková; Igor Sirák
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-25

4.  Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

Authors:  Stephan Kersting; Ralf Konopke; Dag Dittert; Marius Distler; Felix Rückert; Jörg Gastmeier; Gustavo B Baretton; Hans D Saeger
Journal:  J Gastroenterol Hepatol       Date:  2009-05       Impact factor: 4.029

5.  Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer.

Authors:  P J Speicher; X Wang; B R Englum; A M Ganapathi; B Yerokun; M G Hartwig; T A D'Amico; M F Berry
Journal:  Dis Esophagus       Date:  2014-09-12       Impact factor: 3.429

Review 6.  Esophageal cancer: staging system and guidelines for staging and treatment.

Authors:  Mark F Berry
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

7.  Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma.

Authors:  Yaqi Song; Guangzhou Tao; Qing Guo; Xi Yang; Hongcheng Zhu; Wanwei Wang; Xinchen Sun
Journal:  Oncotarget       Date:  2016-04-19

8.  Comparison and Prognostic Analysis of Adjuvant Radiotherapy versus Salvage Radiotherapy for Treatment of Radically Resected Locally Advanced Esophageal Squamous Cell Carcinoma.

Authors:  Xin Xu; Hua-Ying Xie; Di Zhou; Ren-Hua Huang; Yong-Rui Bai; Jun Yuan; Ming Ye
Journal:  Biomed Res Int       Date:  2016-10-16       Impact factor: 3.411

9.  FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.

Authors:  Katharina von Loga; Jule Kohlhaussen; Lia Burkhardt; Ronald Simon; Stefan Steurer; Susanne Burdak-Rothkamm; Frank Jacobsen; Guido Sauter; Till Krech
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older.

Authors:  Shan Huang; Shuyu Zheng; Tuotuo Gong; Hongbing Ma; Yue Ke; Songchuan Zhao; Wenyu Wang; Lijun Jia; Xiaozhi Zhang
Journal:  Oncotarget       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.